Cytori Therapeutics reported $-4116000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Cytori Therapeutics CYTX:US $ -4.12M 0.04M
Dr.Reddys Laboratories DRRD:IN IR 9709M 3016M
Genocea Biosciences GNCA:US $ -15.98M 2.7M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Sun Pharmaceuticals SUNP:IN IR 24661.9M 1796.8M
Teva Pharmaceutical TEVA:IT -175000000 557M